An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

NCT04586244 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision. No safety concerns contributed to this decision.

Conditions

Urothelial Carcinoma

Interventions

DRUG: retifanlimab
DRUG: epacadostat
DRUG: INCAGN02385
DRUG: INCAGN02390

Sponsor

Incyte Corporation